Zhejiang Taimei Medical Technology Co., Ltd.

F:A2V Germany Health Information Services
Market Cap
$104.92 Million
€102.22 Million EUR
Market Cap Rank
#21460 Global
#2330 in Germany
Share Price
€0.51
Change (1 day)
-0.97%
52-Week Range
€0.40 - €0.52
All Time High
€0.52
About

Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders; PharmaOS, a pharmaceutical digital marketing platform; and Ente… Read more

Zhejiang Taimei Medical Technology Co., Ltd. - Asset Resilience Ratio

Latest as of June 2025: 59.01%

Zhejiang Taimei Medical Technology Co., Ltd. (A2V) has an Asset Resilience Ratio of 59.01% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
€896.15 Million
Cash + Short-term Investments
Total Assets
€1.52 Billion
All company assets
Resilience Assessment
Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how Zhejiang Taimei Medical Technology Co., Ltd.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Taimei Medical Technology Co., Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €896.15 Million 59.01%
Total Liquid Assets €896.15 Million 59.01%

Asset Resilience Insights

  • Very High Liquidity: Zhejiang Taimei Medical Technology Co., Ltd. maintains exceptional liquid asset reserves at 59.01% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Zhejiang Taimei Medical Technology Co., Ltd. Industry Peers by Asset Resilience Ratio

Compare Zhejiang Taimei Medical Technology Co., Ltd.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
UCrest Bhd
KLSE:0005
Health Information Services 24.81%
Vanfund Urban Investment & Development Co Ltd
SHE:000638
Health Information Services 0.49%
BIT Computer Co. Ltd
KQ:032850
Health Information Services 26.87%
ezCaretech Co. LTD
KQ:099750
Health Information Services 16.56%
SyntekaBio Inc
KQ:226330
Health Information Services 26.99%
Carelabs Co.Ltd
KQ:263700
Health Information Services 7.01%
Shanghai Kingstar Winning Software
SHE:300253
Health Information Services 0.03%
Longmaster Information Tech
SHE:300288
Health Information Services 0.68%

Annual Asset Resilience Ratio for Zhejiang Taimei Medical Technology Co., Ltd. (2021–2024)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Taimei Medical Technology Co., Ltd..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 55.59% €880.09 Million €1.58 Billion +17.51pp
2023-12-31 38.08% €550.06 Million €1.44 Billion -2.53pp
2022-12-31 40.60% €741.08 Million €1.83 Billion +0.69pp
2021-12-31 39.91% €720.30 Million €1.80 Billion --
pp = percentage points